Neiromidin® is a reversible cholinesterase inhibitor. The medication directly stimulates impulse transmission in the CNS and neuromuscular synapses by blocking membrane K+ ion channels.
Peripheral nervous system diseases (neuritis, polyneuritis, polyneuropathy, polyradiculoneuropathy, myasthenia and myasthenic syndrome of various aetiology), Bulbar paralysis and paresis, Recovery period after organic CNS lesions with motion disorders, Combination therapy of demyelinating diseases, Memory disorders of various origin, Intestinal atonia
Advertiser: AS “Olpha”
Information reviewed on 16.07.2024.
Prescription medicine. Complete summary of product characteristics see on www.zva.gov.lv. Information intended for healthcare specialists.